Liquid biopsy to diagnose EGFR T790M mutation in previously radiated non-small-cell lung cancer brain metastases and rapid response to osimertinib

被引：0
|
作者：
Matzdorff, A. [1 ]
Meier, A. [1 ]
Lenze, D. [2 ]
Hartmann, J. [3 ]
Pielsticker, C. [3 ]
Gawliczek, A. [1 ]
机构：
[1] Asklepios Klinikum Uckermark, Med Klin 2, Schwedt, Germany
[2] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany
[3] Asklepios Klinikum Uckermark, Inst Radiol, Schwedt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P815
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [31] Urine Detection of EGFR T790M Mutation in Non-Small-Cell Lung Cancer: An Outcomes and Total Cost of Care Analysis
    Sands, Jacob
    Hornberger, John
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1191 - S1191
  • [32] Differential efficacy of Osimertinib in EGFR T790M positive non-small cell lung cancer by metastatic site
    Uematsu, Shinya
    ANNALS OF ONCOLOGY, 2019, 30 : 109 - 109
  • [33] Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy
    Filipits, Martin
    Kainz, Verena
    Sebek, Viktor
    Zach, Herwig
    Liquid Biopsy Collaborative Study Grp
    CANCERS, 2023, 15 (13)
  • [34] ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)
    Zhou, Q.
    Zhang, H. -L.
    Jiang, L. -Y.
    Shi, Y. -K.
    Chen, Y.
    Yu, J. -M.
    Zhou, C. -C.
    He, Y.
    Hu, Y. -P.
    Liang, Z. -A.
    Pan, Y. -Y.
    Zhuo, W. -L.
    Song, Y.
    Wu, G.
    Chen, G. -Y.
    Lu, Y.
    Zhang, C. -Y.
    Zhang, C. -Y.
    Zhang, Y. -P.
    Chen, Y.
    Lu, S.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S429 - S430
  • [35] Comparison of Osimertinib versus Almonertinib in T790M+EGFR Non-Small-Cell Lung Cancer Patients
    Li, Yuan
    Zhou, Kun
    Meng, Ying
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [36] Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer
    Nie, Keke
    Zhang, Zhongfa
    Zhang, Chunling
    Geng, Chuanxin
    Zhang, Ling
    Xu, Xiajuan
    Liu, Shichao
    Wang, Songping
    Zhuang, Xingjun
    Lan, Ketao
    Ji, Youxin
    LUNG CANCER, 2018, 121 : 5 - 11
  • [37] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [38] Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan
    Ho, Hsiang-Ling
    Huang, Chao-Cheng
    Ku, Wen-Hui
    Ho, Chung-Liang
    Lin, Chia-Hung
    Yu, Sung-Liang
    Chou, Teh-Ying
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 473 - 476
  • [39] Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
    Joshi, Asim
    Butle, Ashwin
    Hait, Supriya
    Mishra, Rohit
    Trivedi, Vaishakhi
    Thorat, Rahul
    Choughule, Anuradha
    Noronha, Vanita
    Prabhash, Kumar
    Dutt, Amit
    TRANSLATIONAL ONCOLOGY, 2022, 22
  • [40] A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation
    Sakai, Tetsuya
    Udagawa, Hibiki
    Zenke, Yoshitaka
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Ishii, Genichiro
    Goto, Koichi
    CANCER RESEARCH, 2019, 79 (13)
12345